IEEE Open Journal of Engineering in Medicine and Biology,
Journal Year:
2020,
Volume and Issue:
1, P. 243 - 248
Published: Jan. 1, 2020
Goal:
The
aim
of
the
study
herein
reported
was
to
review
mobile
health
(mHealth)
technologies
and
explore
their
use
monitor
mitigate
effects
COVID-19
pandemic.
Methods:
A
Task
Force
assembled
by
recruiting
individuals
with
expertise
in
electronic
Patient-Reported
Outcomes
(ePRO),
wearable
sensors,
digital
contact
tracing
technologies.
Its
members
collected
discussed
available
information
summarized
it
a
series
reports.
Results:
identified
that
could
be
deployed
response
pandemic
would
likely
suitable
for
future
pandemics.
Criteria
evaluation
were
agreed
upon
applied
these
systems.
Conclusions:
mHealth
are
viable
options
patients
used
predict
symptom
escalation
earlier
intervention.
These
also
utilized
who
presumed
non-infected
enable
prediction
exposure
SARS-CoV-2,
thus
facilitating
prioritization
diagnostic
testing.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2021,
Volume and Issue:
unknown
Published: March 26, 2021
Since
late
2019,
the
novel
coronavirus
SARS-CoV-2
has
introduced
a
wide
array
of
health
challenges
globally.
In
addition
to
complex
acute
presentation
that
can
affect
multiple
organ
systems,
increasing
evidence
points
long-term
sequelae
being
common
and
impactful.
The
worldwide
scientific
community
is
forging
ahead
characterize
range
outcomes
associated
with
infection;
however
underlying
assumptions
in
these
studies
have
varied
so
widely
resulting
data
are
difficult
compareFormal
definitions
needed
order
design
robust
consistent
Long
COVID
consistently
capture
variation
outcomes.
Even
condition
itself
goes
by
three
terms,
most
"Long
COVID",
but
also
"COVID-19
syndrome
(PACS)"
or,
"post-acute
infection
(PASC)".
present
study,
we
investigate
used
literature
published
date
compare
them
against
available
from
electronic
records
patient-reported
information
collected
via
surveys.
holds
potential
produce
second
public
crisis
on
heels
pandemic
itself.
Proactive
efforts
identify
characteristics
this
heterogeneous
imperative
for
rigorous
effort
mitigate
threat.
International Journal of Environmental Research and Public Health,
Journal Year:
2021,
Volume and Issue:
18(5), P. 2695 - 2695
Published: March 7, 2021
Background:
Severe
COVID-19
infection
often
leads
to
impairments
requiring
pulmonary
rehabilitation
(PR)
following
the
acute
phase.
Little
is
known
about
efficacy
of
PR
in
these
patients.
We
therefore
compared
post-COVID-19
patients
(PG)
referred
with
other
lung
diseases
(LG).
Methods:
99
PG
were
admitted
PR.
In
a
prospective
design,
results
collected
and
LG
2019
(n
=
419)
according
Functional
Independence
Measurement
(FIM),
Cumulative
Illness
Rating
Scale
(CIRS),
6-min
walk
test
(6-MWT),
duration
PR,
Feeling
Thermometer
(FT).
Results:
According
age,
sex,
CIRS,
both
groups
showed
no
significant
differences.
The
improvements
6-MWT
pre
post
comparison
on
average
180
(±101)
meters
for
102
(±89)
(p
<
0.001).
FT
enhancement
21
(±14)
points
17
(±16)
0.039),
while
FIM
significantly
increased
by
11
(±10)
7
(±8)
Conclusions:
Comprehensive
very
effective
FIM,
FT.
Therefore,
we
recommend
severe
infections.
Chronic Illness,
Journal Year:
2022,
Volume and Issue:
19(2), P. 279 - 303
Published: April 11, 2022
To
analyze
the
published
studies
that
investigated
physical
function,
activities
of
daily
living
and
health-related
quality
life
in
COVID-19
survivors.Systematic
review.We
searched
MEDLINE/PubMed,
Scopus,
SciELO,
Cochrane
Library
for
evaluated
after
from
earliest
date
available
to
July
2021.
Two
independent
reviewers
screened
selected
studies.
The
Newcastle
Ottawa
Scale
was
used
evaluate
methodological
quality.We
included
35
this
systematic
review.
Of
included,
28
were
cohort,
7
cross-sectional
demonstrated
survivors
had
reduced
levels
living,
life.
Furthermore,
incomplete
recovery
performance
observed
1
6
months
post-infection.Physical
disability
reduction
is
a
common
condition
post-COVID-19
impairments
may
persist
up
months.
Researchers
clinicians
can
use
these
findings
understand
potential
disabilities
rehabilitation
needs
people
recovering
COVID-19.
Pneumologie,
Journal Year:
2022,
Volume and Issue:
76(12), P. 855 - 907
Published: Dec. 1, 2022
The
German
Society
of
Pneumology
initiated
2021
the
AWMF
S1
guideline
Long
COVID/Post-COVID.
In
a
broad
interdisciplinary
approach,
this
was
designed
based
on
current
state
knowledge.The
clinical
recommendations
describe
COVID/Post-COVID
symptoms,
diagnostic
approaches,
and
therapies.In
addition
to
general
consensus
introduction,
subject-specific
approach
taken
summarize
has
an
explicit
practical
claim
will
be
developed
adapted
by
author
team
increase
in
knowledge.Die
Deutsche
Gesellschaft
für
Pneumologie
hat
die
S1-Leitlinie
Long-/Post-COVID
initiiert.
einem
breiten
interdisziplinären
Ansatz
wurde
diese
basierend
auf
dem
aktuellen
Wissensstand
gestaltet.Die
klinische
Empfehlung
beschreibt
Long-
bzw.
Post-COVID-Symptome,
diagnostische
Ansätze
und
Therapien.Neben
der
allgemeinen
konsentierten
Einführung
ein
fachspezifischer
Zugang
gewählt,
den
zusammenfasst.Die
Leitlinie
einen
explizit
praktischen
Anspruch
wird
Wissenszugewinn
vom
Autorenteam
weiterentwickelt
adaptiert.
Physiotherapy Research International,
Journal Year:
2024,
Volume and Issue:
29(2)
Published: Feb. 22, 2024
Abstract
Objectives
This
systematic
review
and
meta‐analysis
aims
to
evaluate
the
efficacy
of
pulmonary
rehabilitation
(PR)
in
improving
dyspnea,
fatigue,
physical
activity,
quality
life,
anxiety
depression
patients
with
Long
COVID‐19
(LC).
The
impact
PR
on
LC
a
comparison
face‐to‐face
telerehabilitation
approaches
was
explored.
Methods
followed
PRISMA
guidelines
registered
PROSPERO.
A
literature
search
included
PubMed,
Web
Science,
Cochrane
Library
until
January
2023.
No
language
filters
were
applied.
Randomized
controlled
trials,
non‐randomized
observational
studies
included.
risk
bias
assessed
using
appropriate
tools.
Descriptive
analysis
performed.
Forest
plots
presented
results.
Statistical
analyses
conducted
Metafor
Package
R
v.3.4.2.
Results/Findings
16
patients.
total
1027
adults
varied
design,
seven
studies,
three
quasi‐experimental
six
randomized
trials.
Dyspnea,
function,
psychological
state,
fatigue
as
outcomes.
found
that
had
significant
positive
effect
life
(both
global
domain),
anxiety,
depression.
However,
not
significant.
Heterogeneity
observed
some
analyses,
publication
certain
Age
study
design
identified
potential
moderators.
Both
interventions
improved
studied
outcomes,
only
differences
domain
favoring
group.
Implications
Physiotherapy
Practice
state
patients,
but
fatigue.
Face‐to‐face
have
similar
effects,
except
for
life.
Turkish Journal of Physical Medicine and Rehabilitation,
Journal Year:
2020,
Volume and Issue:
66(4), P. 480 - 494
Published: Dec. 21, 2020
The
novel
coronavirus-2019
(COVID-19)
pandemic
originated
in
Wuhan,
China
late
December
2019,
and
rapidly
spread
to
more
than
200
countries
all
around
the
globe.Currently,
there
are
19.6
million
confirmed
cases
with
727,435
fatalities.
[1][4][5][6]
On
other
hand,
children
may
remain
asymptomatic
most
only
detected
on
laboratory
testing.[5]
main
concern
COVID-19
is
involvement
of
lungs
respiratory
system
which
result
dyspnea,
low
blood
oxygen
saturation,
failure,
thereby,
requiring
mechanical
ventilation,
[3,4]
mostly
those
having
comorbid
conditions
such
as
diabetes
mellitus,
obesity,
ischemic
heart
disease,
cancer,
post-surgery,
chronic
obstructive
pulmonary
disease
(COPD).
[3,5]
European Journal of Physical and Rehabilitation Medicine,
Journal Year:
2021,
Volume and Issue:
57(3)
Published: July 1, 2021
BACKGROUND:
Coronavirus
disease
2019
(COVID-19)
pandemic
is
quickly
spreading
worldwide,
with
survivors
that
suffer
functional
impairments
a
consequent
key
role
of
rehabilitation
in
this
context.
To
date,
there
lack
findings
on
the
postacute
COVID-19
patients.AIM:
Thus,
we
aimed
at
describing
patient-tailored
plan
outcome
hospitalized
patients.DESIGN:
Real-practice
retrospective
study.SETTING:
Inpatients
Rehabilitation
Unit.POPULATION:
Postacute
patients.METHODS:
Medical
records
patients
referred
to
an
Italian
Unit
from
March
10th,
2020
April
30th,
were
collected.
All
underwent
rehabilitative
(30
minutes/set,
2
times/day),
improve
gas
exchanges,
reducing
dyspnoea,
and
improving
muscle
function.
At
admission
(T0)
discharge
(T1),
evaluated
as
measures:
Barthel
Index
(BI),
modified
Research
Council
Dyspnea
Scale,
6-Minute
Walking
Test
(6-MWT)
Borg
Rating
Perceived
Exertion
(RPE)
scale.
We
also
assessed:
type
respiratory
supports
needed,
pulmonary
function,
coagulation
inflammation
markers
length
stay
(LOS)
Unit.RESULTS:
included
41
(25
male
19
female),
mean
aged
72.15±11.07
years.
Their
LOS
was
31.97±9.06
days,
39
successfully
completed
treatment
deceased.
found
statistically
significant
improvement
BI
(84.87±15.56
vs.
43.37±26.00;
P<0.0001),
6-MWT
(303.37±112.18
240.0±81.31
meters;
P=0.028),
RPE
scale
(12.23±2.51
16.03±2.28;
P<0.0001).CONCLUSIONS:
These
suggest
might
beneficiate
motor
treatment.
However,
further
studies
are
advised
better
understand
long-term
sequelae
disease.CLINICAL
REHABILITATION
IMPACT:
This
study
provides
evidence
inpatients
through
Annals of Internal Medicine,
Journal Year:
2020,
Volume and Issue:
174(3), P. 316 - 325
Published: Nov. 23, 2020
Little
is
known
about
recovery
from
coronavirus
disease
2019
(COVID-19)
after
hospital
discharge.To
describe
the
home
health
of
patients
with
COVID-19
and
risk
factors
associated
rehospitalization
or
death.Retrospective
observational
cohort.New
York
City.1409
admitted
to
care
(HHC)
between
1
April
15
June
2020
hospitalization.Covariates
outcomes
were
obtained
mandated
OASIS
(Outcome
Assessment
Information
Set).
Cox
proportional
hazards
models
used
estimate
hazard
ratio
(HR)
death.After
an
average
32
days
in
HHC,
94%
discharged
most
achieved
statistically
significant
improvements
symptoms
function.
Activity-of-daily-living
dependencies
decreased
6
(95%
CI,
5.9
6.1)
1.2
(CI,
1.1
1.3).
Risk
for
death
was
higher
male
(HR,
1.45
[CI,
1.04
2.03]);
White
1.74
1.22
2.47]);
heart
failure
2.12
1.41
3.19]),
diabetes
complications
1.71
1.17
2.52]),
2
more
emergency
department
visits
past
months
1.78
1.21
2.62]),
pain
daily
all
time
1.46
1.05
2.05]),
cognitive
impairment
1.49
2.13]),
functional
1.09
1.00
1.20]).
Eleven
(1%)
died,
137
(10%)
rehospitalized,
23
(2%)
remain
on
service.Care
provided
by
agency.
HHC
discharge
not
available.Symptom
burden
dependence
common
at
admission
but
improved
patients.
Comorbid
conditions
diabetes,
as
well
characteristics
present
admission,
identified
greatest
adverse
event.No
direct
funding.
Journal of Alzheimer s Disease,
Journal Year:
2020,
Volume and Issue:
77(2), P. 459 - 504
Published: Sept. 9, 2020
COVID-19
is
a
severe
infectious
disease
that
has
claimed
>150,000
lives
and
infected
millions
in
the
United
States
thus
far,
especially
elderly
population.
Emerging
evidence
shown
virus
to
cause
hemorrhagic
immunologic
responses,
which
impact
all
organs,
including
lungs,
kidneys,
brain,
as
well
extremities.
SARS-CoV-2
also
affects
patients’,
families’,
society’s
mental
health
at
large.
There
growing
of
re-infection
some
patients.
The
goal
this
paper
provide
comprehensive
review
SARS-CoV-2-induced
disease,
its
mechanism
infection,
diagnostics,
therapeutics,
treatment
strategies,
while
focusing
on
less
attended
aspects
by
previous
studies,
nutritional
support,
psychological,
rehabilitation
pandemic
management.
We
performed
systematic
>1,000
articles
included
425
references
from
online
databases,
including,
PubMed,
Google
Scholar,
California
Baptist
University’s
library.
patients
go
through
acute
respiratory
distress
syndrome,
cytokine
storm,
hypercoagulable
state,
autonomic
dysfunction,
must
be
managed
multidisciplinary
team
nursing,
nutrition,
rehabilitation.
population
those
who
are
suffering
Alzheimer’s
dementia
related
illnesses
seem
higher
risk.
28
vaccines
under
development,
new
strategies/protocols
being
investigated.
future
management
for
should
include
B-cell
T-cell
immunotherapy
combination
with
emerging
prophylaxis.
illness
aspect
among
most
important
side
effects
requires
national
plan
prevention,
diagnosis
treatment.